Left ventricular hypertrophy is characterized by stimulation of ventricular synthesis of atrial natriuretic peptide (ANP). This study was designed to test the hypothesis that the increased ventricular ANP levels participate in the release of ANP into the circulation. Swimming was used as a physiologic model to induce ANP release from the heart, and atrial and ventricular levels of immunoreactive ANP (IR-ANP) and ANP messenger RNA (mRNA) were measured simultaneously in the spontaneously hypertensive (SHR) and Wistar-Kyoto (WKY) rats at rest and after swimming. IR-ANP concentration in the left ventricle of l-year-old SHR with severe left ventricular hypertrophy was increased in association with the augmentation of ANP mRNA levels, whereas right ventricular levels of ANP were reduced in SHR compared with normotensive controls. A 30-minute exercise in hypertensive and in normotensive rats resulted in marked increases in mean arterial pressure, heart rate, plasma catecholamine levels, blood lactate levels, and plasma IR-ANP concentration. The increased ANP secretion was associated with a decrease in left (34-39%) and right (24%) ventricular concentration of IR-ANP; transmurally, this depletion of ventricular IR-ANP was greatest (28%) in the endocardial layer of the left ventricle of SHR. No significant differences were noted in total atrial and left or right auricular IR-ANP concentration between SHR and WKY rats or between the resting and swimming rats. When studied in vitro with an isolated, perfused heart preparation, the hypertrophic ventricular tissue after atrialectomy secreted more ANP into the perfusate than did control hearts; in SHR, ventricles contributed 28% of the total ANP release to perfusate, and in normotensive control rats, ventricles contributed 8%. These studies show that stimulated release of ANP is associated with depletion of endocardial left ventricular stores. The amount of ANP released in vitro and in vivo correlated with the degree of hypertrophy of the ventricle. Finally, the phorbol ester, known to increase ANP secretion from intact perfused hearts, had only a limited effect on ANP release after atrialectomy, suggesting that the secretion of ANP from ventricular cells may be mainly of the constitutive type. (Circulation 1989;80:390-400) A trial natriuretic peptide (ANP), a potent natriuretic, diuretic, and vasorelaxant cardiac hormone that inhibits renin, aldosterone, and vasopressin secretion, is synthesized and secreted predominantly by the atria in healthy adult mammals.1-5 Atrial wall stretch is a predom- The aim of this study was to determine whether or not ventricular ANP levels participate in the release of ANP into the circulation. Physical exercise in the normotensive and genetically hypertensive rats was used as an experimental model to stimulate release of ANP from the heart, and ventricular levels of immunoreactive ANP (IR-ANP) in normal and hypertrophic ventricles were measured at rest and after exercise. In addition, the biosynthesis of ANP in the atria and ventricles, its transmural distribution across the left ventricular wall, and the proportion of ANP secreted from atria and ventricles in vitro from perfused hearts were studied. These studies show that stimulated release of ANP is associated with depletion of endocardial left ventricular stores and that the amount of ANP released correlates with the hypertrophied state of the ventricle.
Left ventricular hypertrophy is characterized by stimulation of ventricular synthesis of atrial natriuretic peptide (ANP). This study was designed to test the hypothesis that the increased ventricular ANP levels participate in the release of ANP into the circulation. Swimming was used as a physiologic model to induce ANP release from the heart, and atrial and ventricular levels of immunoreactive ANP (IR-ANP) and ANP messenger RNA (mRNA) were measured simultaneously in the spontaneously hypertensive (SHR) and Wistar-Kyoto (WKY) rats at rest and after swimming. IR-ANP concentration in the left ventricle of l-year-old SHR with severe left ventricular hypertrophy was increased in association with the augmentation of ANP mRNA levels, whereas right ventricular levels of ANP were reduced in SHR compared with normotensive controls. A 30-minute exercise in hypertensive and in normotensive rats resulted in marked increases in mean arterial pressure, heart rate, plasma catecholamine levels, blood lactate levels, and plasma IR-ANP concentration. The increased ANP secretion was associated with a decrease in left (34-39%) and right (24%) ventricular concentration of IR-ANP; transmurally, this depletion of ventricular IR-ANP was greatest (28%) in the endocardial layer of the left ventricle of SHR. No significant differences were noted in total atrial and left or right auricular IR-ANP concentration between SHR and WKY rats or between the resting and swimming rats. When studied in vitro with an isolated, perfused heart preparation, the hypertrophic ventricular tissue after atrialectomy secreted more ANP into the perfusate than did control hearts; in SHR, ventricles contributed 28% of the total ANP release to perfusate, and in normotensive control rats, ventricles contributed 8%. These studies show that stimulated release of ANP is associated with depletion of endocardial left ventricular stores. The amount of ANP released in vitro and in vivo correlated with the degree of hypertrophy of the ventricle. Finally, the phorbol ester, known to increase ANP secretion from intact perfused hearts, had only a limited effect on ANP release after atrialectomy, suggesting that the secretion of ANP from ventricular cells may be mainly of the constitutive type. (Circulation 1989;80:390-400) A trial natriuretic peptide (ANP), a potent natriuretic, diuretic, and vasorelaxant cardiac hormone that inhibits renin, aldosterone, and vasopressin secretion, is synthesized and secreted predominantly by the atria in healthy adult mammals.1-5 Atrial wall stretch is a predom-inant factor in the regulation of the release of ANP.6-8 Recent evidence shows that biosynthesis of ANP also occurs in extra-atrial tissues, particularly in ventricles.9-12 Increased ventricular ANP synthesis has been shown in patients with congestive heart failure13-16 and in animal models producing cardiac hypertrophy. These models include spontaneous biventricular hypertrophy,17 genetic hypertension,18-20congestive heart failure in cardiomyopathic hamsters,15,21-24 hypoxia,25 administration of high doses of pharmacologic agents,26-29 or sudden circulatory overload due to aortic constriction, myocardial infarction, ureteral constriction, nephrectomy, or arteriovenous shunting.27,30-32The role of the ANP produced by the ventricles is uncertain but could contribute to raised circulatory levels of ANP observed in patients with congestive heart failure.33-36 An alternative explanation for increased ventricular gene expression may be that hypertrophy results in a return to an embryonic state by ventricular cells. 37, 38 The aim of this study was to determine whether or not ventricular ANP levels participate in the release of ANP into the circulation. Physical exercise in the normotensive and genetically hypertensive rats was used as an experimental model to stimulate release of ANP from the heart, and ventricular levels of immunoreactive ANP (IR-ANP) in normal and hypertrophic ventricles were measured at rest and after exercise. In addition, the biosynthesis of ANP in the atria and ventricles, its transmural distribution across the left ventricular wall, and the proportion of ANP secreted from atria and ventricles in vitro from perfused hearts were studied. These studies show that stimulated release of ANP is associated with depletion of endocardial left ventricular stores and that the amount of ANP released correlates with the hypertrophied state of the ventricle.
Methods

Animals
Male spontaneously hypertensive rats (SHR) of the Okamoto-Aoki strain (F65) and age-matched Wistar-Kyoto (WKY) (F63) rats from the colony of the Department of Pharmacology at the University of Oulu, Finland, were used. Both strains were originally obtained from Mollegaards Avslaboratorium, Skensved, Denmark. The rats were housed in plastic cages in a room with controlled humidity of 40% and a temperature of 220 C. A 6:00 AM on and 6:00 PM off environmental light cycle was maintained. Animals were evaluated at ages ranging from 10 to 18 months (mean age, 12±0.4, n=54).
Chronically Instrumented Rats
The surgical preparation and the experimental setup, which have been previously described, 29 To eliminate the possible contribution of contaminating plasma for ventricular ANP levels, hearts were perfused by the Langendorff method as described previously.40 Briefly, immediately after the last blood sample was collected, rats were decapitated, the abdominal cavity was opened, the diaphragm was transsected, lateral incisions were made along both sides of the rib cage, and the heart was cooled with perfusion fluid (4- The blood samples were centrifuged, and ANP was extracted by a modification of a previously described method. 29 The plasma sample (0.5 ml) acidified to pH 4 with 100 ,ul 1 M HCl in 1.6% glycine was applied to a Sep-Pak C18 cartridge (Waters Associates, Milford, Massachusetts) that had been activated previously with methanol followed by triethylamine acetate buffer (20 mM, pH 4.0). After washing with 10 ml 0.1% trifluoroacetic acid, the peptide was eluted with 60% CH3CN in 0.1% trifluoroacetic acid. The eluates were evaporated in a Speed Vac Concentrator (Savant), and the residue was reconstituted with 400 ,ul radioimmunoassay buffer containing 0.1 M sodium phosphate, 0.05 M NaCl, 0.1% Triton-X-100, 0.02% sodium azide, and 0.1% bovine serum albumin, pH 6.0. For the ANP radioimmunoassay, the plasma and tissue extracts were incubated in duplicates of 100 gtl with 100 gl of the middle specific rabbit ANP antiserum in the final dilution of 1/25.000.29,41 After incubation for 48 hours at 80 C, the immunocomplexes were precipitated with sheep antirabbit antiserum in the presence of 500 ,ul 1.2 M ammonium sulphate, pH 7, by centrifuging for 40 minutes at 3,000g. The sensitivity of the assay was 0.8 pg/tube. The turning point of the standard curve was 20 pg/ tube. The ANP values were not corrected for recovery.
ANP mRNA Determination
RNA was isolated from fresh atrial and ventricular tissues of SHR and WKY rats by the guanidine thiocyanate-LiCI method. 42 For the RNA blot analysis,43 1-and 20-,ug samples of the RNA from atria and ventricles, respectively, were fractionated in 1% formaldehyde agarose gels. 44 The RNA on the gel was transferred to Zeta-Probe blotting membrane (Bio-Rad Laboratories) with 10xSCC (lxSCC=0.15 M NaCl, 0.015 M trisodium citrate, pH 7). The full-length rat ANP cDNA probe Car-5545 (a generous gift from Dr. Peter L. Davies, Queens University, Kingston, Canada) was labeled with 32P-dCTP (Amersham, Arlington Heights, Illinois) with a random primed labeling kit (BoehringerMannheim GMBH, Mannheim, FRG). The membrane was hybridized overnight at 65°C in 6 x SCC, 0.8% sodium dodecyl sulfate (SDS), 5xDenhardt's solution, and 100 ,ug/ml sheared herring sperm DNA. After hybridization, the membrane was washed in 0.4 x SCC, 2% SDS 2-3 times for 20 minutes at room temperature, and once in 2% SDS for 45 minutes at 650 C. The membrane was exposed at -70°C to XAR-5 x-ray film (Eastman Kodak, New York) with a Cronex Lightning Plus intensifying screen (DuPont,Wilmington, Delaware) 1 day for the atrial samples and 3 days for the ventricular samples. To quantify the amount of RNA loaded on agarose gels, a 32P-labeled oligonucleotide probe complementary to rat 18 S ribosomal RNA17 was hybridized to all filters as described by Albretsen et al. 46 To estimate tissue ANP mRNA concentration, the ANP:18 S ratio was determined by dividing the absorbance corresponding to ANP probe by the absorbance corresponding to Basic data are summarized in Table 1 . Mean arterial pressure, heart rate, and right atrial pressure, which were measured directly in chronically cannulated conscious rats, were significantly higher in the SHR than in the WKY rats. During blood sampling at rest, mean arterial pressure, heart rate, and right atrial pressure remained constant ( Figure  1 ). Exercise increased mean arterial pressure significantly in the SHR (F=58.1 for group and time interaction,p<O.001) and in the WKY rats (F=18.7, p <0.001). During swimming, mean arterial pressure reached the maximum value within 2 minutes in both strains. In the WKY rats, mean arterial pressure remained elevated throughout the exercise period, whereas in the swimming SHR, blood pressure decreased to basal level after 10 minutes ( Figure  1 ). The heart rate increased rapidly during swimming and remained elevated for 30 minutes in both strains (WKY: F=10.0, p<0.001; SHR: F=12.0, p<0.001, Figure 1) .
The right atrial pressure responses to swimming exercise were variable, depending on whether or not the rats dived. In most WKY rats, right atrial pressure decreased first and then gradually increased. In the WKY rats, the lowest and highest values of right atrial pressure observed during swimming were -0.2+0.8 mm Hg (p<0.05, n=7) and 3.1+0.5 mm Hg (p<0.01), respectively compared with the basal value of 1.0±0.3 mm Hg. In the SHR, right atrial pressure did not decrease significantly (0.5±0.6 mm Hg, n=8), whereas the maximal value observed during swimming (3.1±0.8 mm Hg, p<0.01) was significantly higher than the basal value (1.3±0.3 mm Hg). When all the data were analyzed by two-way analysis of variance, exercise was found to have no significant effect on right atrial pressure in the WKY (F=0.2) and SHR rats (F=0.5) (Figure 1 ). Plasma ANP and Catecholamines and Blood Lactate in SHR and WKYRats
The resting value of plasma IR-ANP concentration was significantly elevated in the SHR compared with the WKY rats (Table 1) , which agrees with our previous findings in the 1-year-old SHR.29 There were no differences in basal levels of plasma IR-ANP between the control and exercise groups (Figure 2) . A significant increase of plasma IR-ANP concentration in response to swimming was seen in the SHR (F=20.8,p<0.001) and WKY rats (F=3.8, p<0.04) (Figure 2) . Values peaked at 10 minutes in the SHR and at 30 minutes in the WKY rats after starting the exercise. Although the amount of ANP released (pg/ml) during exercise was greater in the SHR (Figure 2) , the percent increase of plasma IR-ANP was similar in the WKY rats (240%) to that in the SHR (233%).
Plasma noradrenaline concentrations at the end of the experiments were significantly higher in swimming rats than in the controls for SHR (2,096±95 vs. 306±31 pg/ml, respectively,p<0.001) and WKY (1,473±194 vs. 284±31 pg/ml, respectively, p<0.001). Similarly, the plasma concentration of adrenaline was higher in the swimming than in the controls for SHR (2,630±260 vs (Tables 1 and 2 ). The left ventricular weight and the left ventricular weight to body weight ratios were significantly higher in the SHR than in the WKY rats, whereas their right ventricular weights and the right ventricular weight to body weight ratios did not differ significantly ( Table  2) . The left to right ventricular weight ratio was greater in the SHR than in the WKY rats ( Table 2) .
The ventricular weight to body weight ratio of SHR used for the mRNA measurements (4.13+0.13 mg/g, n =6) was also significantly greater than that of age-matched WKY rats (2.94+0.02 mg/g, n=5, p<0.001). The ventricular weight to body weight ratio of SHR used for the atrialectomy study was 4.93+±0.26 mg/g (n=7), and that of WKY rats was 3.08+0.07 mg/g (n=6, p<0.001).
Atnial and Ventricular Levels of Immunoreactive ANP and ANP mRNA in SHR and WKY Rats Total atrial IR-ANP content (,gg/atria) and left and right auricle IR-ANP contents did not differ between control SHR and WKY rats (Table 3) .
Right auricular IR-ANP concentration was 1.7-1.8 times higher than that of left auricle in both strains, but no substantial differences were noted in auricular or total atrial ANP concentration between control WKY and SHR rats (Table 3) . Swimming had no effect on total atrial or right auricular IR-ANP in SHR and WKY rats. Left auricular IR-ANP content (jig/auricle) was lower in the swimming than resting SHR rats. Left auricular IR-ANP concentration was slightly lower in swimming SHR (17%) and in WKY (6%) rats, but the difference between swimming and control groups was not significant.
As shown in Table 3 , ventricular content of IR-ANP (ng/ventricle) was about 150 times lower than atrial IR-ANP content (,u/atria) in the resting WKY rats. Total and left ventricular IR-ANP concentrations were 2.5-and 3.0-fold higher, respectively, in the SHR than in WKY rats. The IR-ANP levels of the right ventricle were lower in the SHR compared with WKY rats. Swimming consistently decreased ventricular ANP levels, the differences between the control and exercise groups being significant for SHR rats (Table 3) . Left 
Transmural Distribution of Ventricular ANP and Effect of Swimming
The average left ventricular IR-ANP concentration was 1.83±0.33 ng/mg protein in the resting WKY rats and 3.71±0.25 ng/mg protein in the SHR (p<O.OOl). The regional left ventricular IR-ANP concentration in resting WKY rats was 3.4-and 2.6-fold higher in the endocardium than in the outermost third and the midwall of the left ventricle, respectively ( Figure 3 ). SHR had a 5.5-fold difference between endocardial and epicardial left ventricular IR-ANP concentration and 2.8-fold difference between the endocardium and the midwall of left ventricle. When analyzed by the two-way analysis of variance, the difference between the transmural distribution of IR-ANP concentration in the SHR and WKY rats was highly significant (F=12.09,p<0.001); this difference was greatest in Figure 3) ; in swimming SHR, the endocardial ventricular levels of IR-ANP (ng/mg protein) were 30% lower than in the resting group; and in the swimming WKY, levels were 22% lower than in the resting group. If (Figure 3 ). Release ofANP From Isolated, Perfused SHR and WKY Rat Hearts The basal release of IR-ANP was significantly higher from the perfused SHR hearts (3.65+±0.33 ng/min,p<0.01, n=7) compared with that of hearts from normotensive rats (2.05±0.34 ng/min, n=6) ( Figure 4) . Atrialectomy decreased perfusate IR-ANP concentration significantly in both strains: in SHR from 730±67 to 202±28 pg/ml (p<0.001) and in WKY rats from 409 ±69 to 31±6 pg/ml (p<O0.001). Thus, after atrialectomy, SHR hearts secreted 28% (1.01±0.14 ng/min) and WKY hearts 8% (0.16±0.03 ng/min) of the amount of IR-ANP secreted into perfusion fluid before atrialectomy.
Infusion of TPA at a concentration of 0.5x 10-7 after atrialectomy had only a small effect on ANP release. In the SHR, maximal concentration of IR-ANP during the infusion (264±51 pg/ml compared with preinfusion level of 192±26 pg/ml, NS) was observed after 18 minutes, and in the WKY rats, maximal concentration (76±31 pg/ml vs. preinfusion level 29±7 pg/ml, p<0.01) occurred at 24 minutes after starting the TPA infusion. In both strains, TPA 54 Increased atrial wall stretch appears to be the major signal for its release,3-8 but there is in vivo and in vitro evidence for the sensitivity of the atria to secretagogues. 7, 8, [55] [56] [57] [58] [59] [60] In the present studies, swimming was used as a physiologic model to induce ANP release from the heart. This experimental approach increases cardiac work load in rats,61 and physical exercise increases the levels of plasma IR-ANP in humans.36 In our experiments, the mean arterial pressure and heart rate, the marked increases in plasma noradrenaline, adrenaline, and blood lactate concentrations indicated that swimming increased the work load of the heart in WKY and SHR rats. These hemodynamic and hormonal changes during exercise produced 3.3-3.4-fold increase in plasma IR-ANP concentration in SHR and WKY rats. The maximal increase in the ANP levels in response to swimming was comparable to that produced by acute volume loading with saline in these strains. 29 Of note, in the SHR, mean arterial pressure and plasma IR-ANP decreased toward the end of the swimming period but remained elevated in WKY rats, suggesting a possible relation between blood pressure and plasma IR-ANP levels.
To examine the effect of the stimulated release on cardiac ANP stores, IR-ANP levels were measured in atria and ventricles in the swimming and resting SHR and WKY rats. The results of our present study convincingly show a link between myocardial hypertrophy, ventricular ANP synthesis, and release of this peptide hormone. The total content of ventricular ANP was 2.5 times higher in the SHR than in WKY rats. As a result of left ventricular hypertrophy and increased ventricular IR-ANP concentration in SHR, the proportion of ventricular ANP from total cardiac ANP content was also greater in SHR. In To test this hypothesis, we examined the ability of normal and hypertrophic ventricular tissue to secrete ANP in response to phorbol ester infusion in vitro after atrialectomy. Previously, we showed that when intact rat hearts are used, TPA, which mimics the action of diacylglycerol by directly activating protein kinase C, induces a 3-5-fold increase in perfusate IR-ANP concentration.7,5863 Addition of TPA into the perfusion fluid led only to small changes in ANP secretion after atrialectomy, suggesting that both normal and hypertrophied ventricular tissue may secrete ANP predominantly by a constitutive pathway. The observations that stimulated release of ANP depleted left ventricular endocardial stores (this study) and that secretory granules are not located in the subendocardial half of the left ventricle but seem to be scattered throughout the thickness of the ventricular wall23 further suggest that the release from ventricles is controlled mainly mechanically (pressure and volume), whereas release from the atria is also mediated by secretagogues.
In the normal heart, any change in cardiac performance that increases cardiac filling pressure is detected in the atria and leads to the release of ANP from the heart, which is an effect that may be potentiated by vasopressor hormones. Once released, atrial peptides exert potent direct vasodilator and natriuretic actions and function as a neurohumoral antagonist; these effects unload the distended heart. In ventricular hypertrophy, atrial peptides are synthesized in ventricular and atrial cardiocytes. Based on the present studies, the ventricular source substantially contributes to the circulating level of ANP, and the amount released depends on the hypertrophic state of ventricular tissue. The stimulated release of ANP from ventricles seems to occur mainly by the constitutive pathway and selectively affects left ventricular endocardial stores.
